Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro

被引：0
|
作者：
Han Qiao
Ting-yu Wang
Wei Yan
An Qin
Qi-ming Fan
Xiu-guo Han
Yu-gang Wang
Ting-ting Tang
机构：
[1] Shanghai Key Laboratory of Orthopaedic Implants,Department of Orthopaedic Surgery
[2] Shanghai Ninth People's Hospital,Department of Pharmacy
[3] Shanghai Jiao Tong University School of Medicine,undefined
[4] Shanghai Key Laboratory of Orthopaedic Implants,undefined
[5] Shanghai Ninth People's Hospital,undefined
[6] Shanghai Jiao Tong University School of Medicine,undefined
[7] Shanghai Key Laboratory of Orthopaedic Implants,undefined
[8] Wendeng Zhenggu Hospital of Shandong Province,undefined
来源：
Acta Pharmacologica Sinica | 2015年 / 36卷
关键词：
plumbagin; zoledronic acid; anticancer agent; human breast cancer; synergism; apoptosis; Notch-1; Bcl-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1085 / 1098
页数：13
相关论文
共 50 条
  • [1] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro
    Qiao, Han
    Wang, Ting-yu
    Yan, Wei
    Qin, An
    Fan, Qi-ming
    Han, Xiu-guo
    Wang, Yu-gang
    Tang, Ting-ting
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1085 - 1098
  • [2] Author Correction: Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro
    Han Qiao
    Ting-yu Wang
    Wei Yan
    An Qin
    Qi-ming Fan
    Xiu-guo Han
    Yu-gang Wang
    Ting-ting Tang
    [J]. Acta Pharmacologica Sinica, 2019, 40 : 1127 - 1128
  • [3] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro (vol 36, pg 1085, 2015)
    Qiao, Han
    Wang, Ting-yu
    Yan, Wei
    Qin, An
    Fan, Qi-ming
    Han, Xiu-guo
    Wang, Yu-gang
    Tang, Ting-ting
    [J]. ACTA PHARMACOLOGICA SINICA, 2019, 40 (08) : 1127 - 1128
  • [4] In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
    Ural, A. Ugur
    Avcu, Ferit
    Candir, Muhammed
    Guden, Metin
    Ozcan, M. Ali
    [J]. BREAST CANCER RESEARCH, 2006, 8 (04)
  • [5] Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro
    Neville-Webbe, HL
    Evans, CA
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1598 - 1598
  • [6] Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid
    Ullén, A
    Lennartsson, L
    Harmenberg, U
    Hjelm-Eriksson, M
    Kalkner, KM
    Lennernäs, B
    Nilsson, S
    [J]. ACTA ONCOLOGICA, 2005, 44 (06) : 644 - 650
  • [7] Growth inhibition in human breast cancer cells with the combination of a PKC inhibitor and zoledronic acid.
    Witters, LM
    Green, J
    Seaman, J
    Lipton, A
    Milton, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S166 - S166
  • [8] In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells
    Arai, N.
    Inoue, S.
    Tomihara, K.
    Tsuno, H.
    Noguchi, M.
    [J]. ORAL DISEASES, 2013, 19 (02) : 200 - 205
  • [9] The effects of zoledronic acid and doxorubicin in combination on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, H
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1299 - 1299
  • [10] Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
    Neville-Webbe, HL
    Evans, CA
    Colemana, RE
    Holen, I
    [J]. TUMOR BIOLOGY, 2006, 27 (02) : 92 - 103
12345